Gibson, Iain R.
Lopes, Viviana R.
Oliver, Rema
Wang, Tian
Wills, Dan
Buckland, Tom
Walsh, William R.
Funding for this research was provided by:
Innovate UK (Grant no. 103853, Grant no. 103853, Grant no. 103853, Grant no. 103853, Grant no. 103853, Grant no. 103853)
Article History
Received: 17 December 2024
Accepted: 19 March 2025
First Online: 11 April 2025
Declarations
:
: The pre-clinical study was reviewed and approved by the ethics committee of the University of New South Wales.
: Not applicable.
: TB was an employee and stockholder of Sirakoss Ltd, and is now an employee of OssDsign AB. VRL is an employee of OssDsign AB. WRW and IRG were stockholders of Sirakoss Ltd. TB, WRW and IRG receive royalty payments from OssDsign AB. The remaining authors declare no conflicts of interest.